Alyvant

Alyvant is a technology-enabled commercialization company and a subsidiary of Roivant Sciences. The company utilizes its proprietary Iterative Learning Platform to analyze large-scale healthcare data, aiming to identify undiagnosed patients and optimize physician targeting for pharmaceutical sales. By integrating data science with traditional commercial strategies, Alyvant seeks to improve the efficiency of drug launches and market penetration. It has historically supported the commercial efforts of other Roivant 'Vants,' such as Myovant and Urovant, particularly in the fields of urology and women's health. The company's approach focuses on reducing the high costs associated with traditional pharmaceutical marketing through the use of artificial intelligence and predictive analytics.